Growth Metrics

Volitionrx (VNRX) Receivables - Net (2012 - 2025)

Volitionrx posted quarterly Receivables - Net of $317808.0 for Q4 2025, up 901.44% year-on-year from $31735.0 in Q4 2024, and up 2.82% on a QoQ basis from $309085.0 in Q3 2025.

Volitionrx (VNRX) has 8 years of Receivables - Net data on file, last reported at $317808.0 in Q4 2025.

  • For the quarter ending Q4 2025, Receivables - Net rose 901.44% year-over-year to $317808.0; the trailing twelve-month figure through Dec 2025 stood at $317808.0 (up 901.44% YoY), and the FY2025 full-year result was $317808.0, up 901.44% from the prior year.
  • Receivables - Net for Q4 2025 stood at $317808.0, up from $309085.0 in the prior quarter.
  • Across five years, Receivables - Net topped out at $317808.0 in Q4 2025 and bottomed at $5492.0 in Q3 2022.
  • The 5-year median for Receivables - Net is $72609.0 (2022), against an average of $116792.4.
  • The widest annual swing landed in 2021, when Receivables - Net surged 5783.47%; it then tumbled 71.93% in 2022.
  • A 5-year view of Receivables - Net shows it stood at $12510.0 in 2021, then surged by 480.41% to $72609.0 in 2022, then slumped by 52.57% to $34441.0 in 2023, then decreased by 7.86% to $31735.0 in 2024, then jumped by 901.44% to $317808.0 in 2025.
  • The last three Receivables - Net figures came in at $317808.0 (Q4 2025), $309085.0 (Q3 2025), and $189597.0 (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Volitionrx 101.83 Mn 99.36 Mn -1.01 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 317,808.00
Dec 31, 2025 317,808.00
Sep 30, 2025 309,085.00
Sep 30, 2025 309,085.00
Jun 30, 2025 189,597.00
Jun 30, 2025 189,597.00
Mar 31, 2025 187,830.00
Mar 31, 2025 187,830.00
Dec 31, 2024 31,735.00
Dec 31, 2024 31,735.00
Sep 30, 2024 312,611.00
Sep 30, 2024 312,611.00
Jun 30, 2024 166,262.00
Jun 30, 2024 166,262.00
Mar 31, 2024 133,500.00
Mar 31, 2024 133,500.00
Sep 30, 2023 34,441.00
Sep 30, 2023 34,441.00
Jun 30, 2023 196,487.00
Jun 30, 2023 196,487.00
Mar 31, 2023 118,592.00
Mar 31, 2023 118,592.00
Dec 31, 2022 72,609.00
Dec 31, 2022 72,609.00
Sep 30, 2022 5,492.00
Sep 30, 2022 5,492.00
Jun 30, 2022 8,489.00
Jun 30, 2022 8,489.00
Mar 31, 2022 72,371.00
Mar 31, 2022 72,371.00
Dec 31, 2021 12,510.00
Dec 31, 2021 12,510.00
Sep 30, 2021 19,566.00
Sep 30, 2021 19,566.00
Jun 30, 2021 15,832.00
Jun 30, 2021 15,832.00
Mar 31, 2021 14,238.00
Mar 31, 2021 14,238.00
Dec 31, 2020 7,118.00
Dec 31, 2020 7,118.00
Sep 30, 2020 573.00
Sep 30, 2020 573.00
Jun 30, 2020 3,223.00
Jun 30, 2020 3,223.00
Mar 31, 2020 242.00
Mar 31, 2020 242.00
Sep 30, 2019 16,031.00
Sep 30, 2019 16,031.00
Sep 30, 2012 933.00
Sep 30, 2012 933.00
Jun 30, 2012 11,707.00
Jun 30, 2012 11,707.00
Mar 31, 2012 15,672.00
Mar 31, 2012 15,672.00